Insulin resistance undermines the advantages of IL28B polymorphism in the pegylated interferon alpha-2b and ribavirin treatment of chronic hepatitis C patients with genotype 1. (Q42980555)
Jump to navigation
Jump to search
scientific article published on 18 May 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Insulin resistance undermines the advantages of IL28B polymorphism in the pegylated interferon alpha-2b and ribavirin treatment of chronic hepatitis C patients with genotype 1. |
scientific article published on 18 May 2012 |
Statements
1 reference
Insulin resistance undermines the advantages of IL28B polymorphism in the pegylated interferon alpha-2b and ribavirin treatment of chronic hepatitis C patients with genotype 1. (English)
1 reference
Eiichi Ogawa
1 reference
Norihiro Furusyo
1 reference
Masayuki Murata
1 reference
Hiroaki Ikezaki
1 reference
Takeshi Ihara
1 reference
Takeo Hayashi
1 reference
Kazuhiro Toyoda
1 reference
Hiroaki Taniai
1 reference
Kyoko Okada
1 reference
Mosaburo Kainuma
1 reference
Jun Hayashi
1 reference
18 May 2012
1 reference
1 reference
57
1 reference
3
1 reference
534-540
1 reference
Identifiers
1 reference
1 reference